PrintResearchers have proved it is possible to cultivate a network of brain cells that reconnect on a silicon chip—the brain on a microchip—by developing a neurochip technology that monitors brain cell activity at a higher resolution than has yet been achieved.
Read More
Cancer
Pancreatic Cancers Use Fructose to Fuel GrowthStudy’s findings challenge general notions about sugars. Read More.Clinical Trials
Favorable OutcomesDrug trials funded by industry are more likely to publish positive results. Read More.Nanotechnology
Painless ProtectionResearchers develop a dissolvable needle-free nanopatch for vaccine delivery. Read More.Stem Cells
Holding on to the PastReprogrammed adult stem cells may not be as versatile as first thought. Read More.Infectious Disease
Scientists Develop First Malaria-Proof MosquitoApproach seeks way around problems of development, manufacturing, and distributing drug to treat the disease. Read More.HIV/AIDS
Giving HIV the FingerSangamo’s ZFN technology generates HIV-resistant human stem cells. Read More.Drug Development
Do They Make A Pill That Can Fix This?Global pharmaceutical R&D; productivity is declining. Read More.Drug Development
Researchers Find an Easier Way to Synthesize New Drug CandidatesScientists say their method could have a big impact on pharmaceutical business. Read More.Personalized Medicine
Crafting a Personalized Medicine Pathway FDA and NIH heads seek to connect the steps between discovery through the approval of a therapy for clinical use. Read More.Cancer
And the Winners Are...As the much-watched cancer conference ASCO ends, few stocks get a lift from news at the event. Read More.Cancer
Attacking Tumors Before They DevelopPrototype vaccine prevents breast cancer formation in mice. Read More.Cancer
Put Your Money Where Your Metastases AreOnly 5 percent of cancer research funding in Europe is spent on the spread of cancer cells in the body, yet it kills 90 percent of all cancer patients. Read More.Neurodegeneration
An Unfolding Natural Disaster Cumulative costs of Alzheimer’s in the United States will top $20 trillion over the next 40 years. Read More.Industrial Bio/Ag Bio
DIY LifeJ. Craig Venter Institute Researchers make first self-replicating synthetic bacterial cell. Read More.Research
The Repurpose Driven LifePfizer and Washington University collaborate to find new uses for old drugs. Read More.
.gif)
.gif)
- Two New Paths to the Dream: Regeneration
The New York Times - Medical Device Makers Face Revamped U.S. Rules for Approvals
Bloomberg - Pfizer May Gain as U.S. Devises Speedy Alternative to Animal Safety Tests
Bloomberg - Judge lets Virginia healthcare challenge proceed
Reuters - F.D.A. Clears Way for Embryonic Stem Cell Trial Using Patients
The New York Times - Technologies Help Adult Children Monitor Aging Parents
The New York Times - Pfizer's Viagra Weighed by U.S. FDA for Children With Rare Lung Disorder
Bloomberg - New Health Official Faces Hostility in Senate
The New York Times - Pharma seeks FDA clarity on risky drug safeguards
Reuters - Special report: Targeting teens for gastric bands
Reuters